Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

451-460 of 6326 results

Catalogue Number:

bsm-60226R

Category:

D

Bioss logo

–

Target: ITGAE/CD103
Target Alias Names: alpha-E1, alpha-M290, aM290, Antigen CD103, CD 103, CD103, CD103 antigen, HML 1 antigen, HML1 antigen, Human mucosal lymphocyte antigen 1, Human mucosal lymphocyte antigen 1, alpha subunit, Huminae, Integrin alpha E heavy chain, Integrin alpha E light chain, Integrin alpha E, epithelial-associated, Integrin alpha E1, Integrin alpha IEL, Integrin alpha M290, Integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1, alpha polypeptide), Integrin, alpha E, ITGAE, MGC141996, MGC183601, Mucosal lymphocyte 1 antigen, Mucosal lymphocyte antigen 1
Species Reactivity: Other
Applications: Immunofluorescence, Immunohistochemistry
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60227R

Category:

D

Bioss logo

–

Target: ICOS
Target Alias Names: Inducible T-cell costimulator, Activation inducible lymphocyte immunomediatory molecule, Activation-inducible lymphocyte immunomediatory molecule, AILIM, CD278, CD278 antigen, CVID1, ICOS_HUMAN, Inducible costimulator, Inducible T cell co stimulator, MGC39850.
Species Reactivity: Human
Applications: Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60228R

Category:

D

Bioss logo

–

Target: LMO2
Species Reactivity: Human
Applications: Immunofluorescence, Immunohistochemistry
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60229R

Category:

D

Bioss logo

–

Target: delta 1 Catenin
Species Reactivity: Human
Applications: Immunofluorescence, Immunohistochemistry
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60231R

Category:

D

Bioss logo

–

Target: CD7
Target Alias Names: CD7 antigen (p41), CD7 molecule, CD7_HUMAN, T-cell antigen CD7, T-cell leukemia antigen, T-cell surface antigen Leu-9, CD 7, CD7 antigen, CD7 antigen p41, CD7 molecule, GP 40, GP40, LEU 9, LEU9, p41, p41 protein, T cell antigen CD7, T cell antigen CD7 precursor, T cell leukemia antigen, Tp 40, TP 41, Tp40, TP41.
Species Reactivity: Human
Applications: Immunofluorescence, Immunohistochemistry, Western Blot
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60233R

Category:

D

Bioss logo

–

Target: CD22
Target Alias Names: B-cell receptor CD22, B cell receptor CD22 precursor, B lymphocyte cell adhesion molecule, BL CAM, BL-CAM, BLCAM, CD 22, CD22 antigen, CD22 molecule, CD22 protein, Leu14, Lyb8, MGC130020, Sialic acid binding immunoglobulin like lectin 2, SIGLEC 2, SIGLEC2, SIGLEC-2, FLJ22814, MGC130020, CD22_HUMAN, B-lymphocyte cell adhesion molecule, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14.
Species Reactivity: Human
Applications: Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Western Blot
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60234R

Category:

D

Bioss logo

–

Target: SOX-10
Target Alias Names: DOM, MGC15649, SOX 10, SOX10_HUMAN, SRY (sex determining region Y) box 10, SRY box containing gene 10, SRY related HMG box gene 10, Transcription factor SOX 10, Transcription factor SOX-10, WS4.
Species Reactivity: Human, Mouse, Rat
Applications: Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Western Blot
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60236R

Category:

D

Bioss logo

–

Target: IDO1
Target Alias Names: Indoleamine 2, 3-dioxygenase, 3-dioxygenase, I23O1_HUMAN, IDO 1, IDO, IDO-1, INDO, indolamine 2, 3 dioxygenase, Indole 2 3 dioxygenase, indoleamine 2 3 dioxygenase 1, indoleamine 2 3 dioxygenase, Indoleamine 2, 3-dioxygenase 1, Indoleamine pyrrole 2 3 dioxygenase, Indoleamine-pyrrole 2, indoleamine-pyrrole 2, 3 dioxygenase.
Species Reactivity: Human
Applications: Immunofluorescence, Immunohistochemistry
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60237R

Category:

D

Bioss logo

–

Target: CD43
Species Reactivity: Human
Applications: Flow Cytometry, Western Blot
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Rabbit
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method Naïve display libraries from animal B cells
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo

Catalogue Number:

bsm-60238M

Category:

D

Bioss logo

–

Target: SNAP25
Target Alias Names: SNAP-25, bA416N4.2, Bdr, dJ1068F16.2, FLJ23079, HGNC:11132, MGC105414, MGC139754, Resistance to inhibitors of cholinesterase 4 homolog, RIC 4, RIC4, SEC9, SNAP 25, SNAP, SNAP-25B, SNP 25, SNP25, sp, SUP, Super protein, Synaptosomal associated 25 kDa protein, Synaptosomal associated protein, Synaptosomal Associated Protein 25, Synaptosomal associated protein 25kDa, SNP25_HUMAN.
Species Reactivity: Mouse, Rat
Applications: Immunofluorescence, Immunohistochemistry, Western Blot
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Mouse
Formulation: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Animal-Derived Biomaterials Used: BSA
Sequence Available No
Original Discovery Method recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
Bioss logo